Tag: Novartis Pharmaceuticals

First Mobile App for Carcinoid and Neuroendocrine Cancer Community Goes Live

The first mobile app for carcinoid cancer and neuroendocrine tumor (NET) patients is now available for downloading on the iPhone, iPad, and Android!  My NET Manager, a free app provided by Novartis Oncology, offers patients a unique opportunity to track…

National Carcinoid and NET Patient Conference: Have You Registered?

Have you registered for the national carcinoid and NET patient conference in New Orleans, September 20 – 22?  The hotel is over 90% booked and registration is nearing capacity!  This is a wonderful opportunity to learn more about carcinoid and …

10 Highlights of the Year 2011 for the Carcinoid and Neuroendocrine Tumor Community

As the Carcinoid Cancer Foundation looks back on the year 2011, there were many significant events and advances for the carcinoid and neuroendocrine tumor (NET) community.  Here are 10 of the year’s important stories:

1)     The FDA approved the first…